Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:23 PM UTC
| NCT Number | NCT07440225 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | PHASE2 |
| Target Enrollment | 960 participants |
| Active Locations | 67 sites in the US |
| Sponsor | EyeBiotech Ltd. |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07440225 is currently recruiting participants. This phase2 study for macular degeneration is actively seeking new participants at 67 locations across the United States. The study is sponsored by EyeBiotech Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07440225 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 67 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07440225 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.